Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
CJC-1295 / Ipamorelin What It Is: A synthetic growth-hormone-releasing peptide stack combining CJC-1295, a modified growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective ghrelin-receptor agonist (growth hormone secretagogue)
The solution is typically clear blue
You can transfer it to TelyRx directly
B12 is crucial in brain function, nerve tissue health, and red blood cell production
What weight-loss outcomes are observed with tirzepatide
WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
US$ 28.55
US$ 27.32
US$ 24.56
US$ 24.56
US$ 21.88
